While mega-cap tech companies continue to dominate the narrative, a significant wave of restructurings and strategic pivots is quietly reshaping the rest of the US market. I'm told that behind closed doors, companies spanning from traditional retail behemoths to niche semiconductor players are making critical divestments and executive shakeups to prepare for the latter half of 2026.

Kroger (KR.US)

Kroger is navigating inflationary pressures with remarkable resilience, and its recent trajectory has outpaced some of its retail peers. The company reported a solid USD 46.1B in total sales for Q1 2026, with identical sales without fuel steadily climbing. According to people familiar with the matter, beyond the 19% growth in its digital commerce segment, Kroger is aggressively executing its previously authorized USD 2B share buyback program, signaling deep management confidence in its cash flow generation through the end of fiscal 2026.

Cheniere Energy (LNG.US)

The US liquefied natural gas giant has faced recent market headwinds fueled by heightening geopolitical tensions in the Middle East. I'm told the company reported a massive USD 4.8B derivative loss tied to LNG in Q1 2026. However, its core expansion remains completely on track. Cheniere recently signed an EPC contract with Bechtel for the first phase of the Sabine Pass expansion project, locking in long-term capacity for international markets.

Canaan (CAN.US)

Canaan is executing one of its most significant overhauls in recent years. I'm told that the company has officially decided to terminate its non-core AI semiconductor business unit. According to insiders, Canaan will now focus entirely on its Avalon-branded Bitcoin miners and proprietary mining operations. This contrarian "anti-AI" pivot has sparked considerable debate, especially amidst ongoing volatility in the cryptocurrency sector.

Valens Semiconductor (VLN.US)

This semiconductor player focused on audio-video and automotive connectivity delivered a Q1 2026 performance that topped estimates. Valens reached USD 16.9M in revenue, with non-GAAP gross margins exceeding the higher end of their guidance. I've also learned that the recent appointment of Karine Pinto-Flomenboim as CFO in June is aimed at tightening capital allocation as the company targets moderate revenue growth later this year.

SIGA Technologies (SIGA.US)

SIGA is gearing up for a massive delivery phase in its infectious disease countermeasures. While Q1 2026 total revenue stood at USD 6.2M, the real catalyst lies ahead. The company is set to deliver USD 13M of oral TPOXX to an international customer in Q2, followed by a USD 26M delivery of IV TPOXX to the US Strategic National Stockpile by the end of Q3.

Also

• Team Inc (TISI.US): The industrial services provider hit its highest Q1 revenue since 2019, growing 8.3% year-over-year to USD 215.1M and significantly narrowing its net losses.
• Aduro Clean Technologies (ADUR.US): I'm told the clean-tech firm intentionally brought its Q3 fiscal 2026 revenue to zero as it fully redirects its resources toward scaling up its chemical recycling technologies, backed by a recent USD 20M public offering.
• GH Research (GHRS.US): The biopharma company has published its phase 2b trial results for Treatment-Resistant Depression (TRD) and is now seeking aligned FDA feedback on its global phase 3 program design.
• Nexera Technologies (NEXR.US): Following a major strategic transition into the homeland security market, the AI-driven data company saw its 2025 fiscal revenue grow 23% year-over-year to USD 16.83M.
• GeneDx (WGS.US): The health insights company continues to leverage its massive genomic and exome datasets to provide actionable clinical data for healthcare providers.

This article does not constitute investment advice.